Actively Recruiting
CRATER Trial: Coronary Rotational Atherectomy Elective vs. Bailout in Patients With Severely Calcified Lesions and Chronic Renal Failure
Led by Guillermo Galeote; MD, PhD · Updated on 2022-04-29
124
Participants Needed
1
Research Sites
48 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the use of rotational atherectomy in patients with severely calcified coronary artery lesions, especially those with chronic kidney disease, which is linked to more severe arterial calcification. The study aims to compare the healthcare costs and outcomes between elective rotational atherectomy and conventional angioplasty (bailout) in this patient group, as there is currently no direct randomized comparison using intravascular ultrasound to assess calcification severity. Participants will be randomly assigned to either receive elective rotational atherectomy or start with conventional angioplasty, with rotational atherectomy used only if needed as a bailout. The procedure uses a Rotablator system that rotates a diamond-coated burr to remove calcified plaque, followed by intravascular ultrasound-guided stent placement. The study evaluates costs, success of stent expansion, procedure time, radiation exposure, complications, and cardiovascular events over medium-term follow-up. During the study, participants will undergo detailed imaging with intravascular ultrasound, angioplasty, and stent placement procedures. Researchers will monitor healthcare costs up to 30 days and over 5 years, procedure and fluoroscopy times, contrast-induced kidney injury, periprocedural and in-hospital complications, and major cardiovascular events up to 5 years after the procedure. The total participation duration includes these follow-up periods to assess safety and outcomes.
CONDITIONS
Brief Title
Coronary Rotational Atherectomy Elective vs. Bailout in Severely Calcified Lesions and Chronic Renal Failure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients over 18 years old
- Chronic kidney disease with glomerular filtration rate below 60 mL/min/1.73 m2 for 3 months or more
- Coronary artery stenosis of 70% or greater in vessels 2.5 mm or larger
- Severe calcification visible on both sides of the coronary artery lumen
- Any clinical situation except acute myocardial infarction within the first 7 days
- Native coronary vessels or bypass grafts eligible
You will not qualify if you...
- No informed consent provided
- Acute myocardial infarction within the first 7 days
- Lesion in only one patent vessel
- Calcified lesions with angulation greater than 60 degrees, dissections, thrombus, or degenerated vein grafts
- Hemodynamically unstable patients
- Allergy to iodinated contrast media
- Significant other illnesses with life expectancy under one year
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Periprocedural period including hospitalization until discharge
Participants receive a coronary procedure using either elective rotational atherectomy or conventional angioplasty with possible bailout atherectomy, guided by intravascular ultrasound to treat severely calcified coronary lesions.
1 procedure visit and hospitalization stay
Duration - Up to 5 years after the procedure
Participants are monitored for major cardiovascular events and healthcare outcomes up to 5 years after the procedure.
Visits at 1, 2, 3, 4, and 5 years after procedure
Trial Site Locations
Total: 1 location
1
La Paz University Hospital
Madrid, Spain, 28046
Actively Recruiting
Research Team
G
Guillermo Galeote, PhD, MD
A
Artemio García-Escobar, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here